Despite all economic pressures, the domestic production share of pharmaceutical raw materials have increased from 54 percent in 2016 to 67 percent in 2018, declining Iran’s dependence on these materials by 33 percent, he said on Tuesday.
He went on to say that manufacturing two-thirds of pharmaceutical raw materials inside the country are a unique record in the region and even internationally.
Touching upon the Leader of Islamic Revolution’s permission for withdrawing $500 million from Iran's sovereign wealth fund to support pharmaceutical companies, Asghari added that these kinds of measures will speed up the progress of such domestic productions trends.
MAH/4451411
Your Comment